Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

25.99
-0.6500-2.44%
Pre-market: 26.100.1100+0.42%07:31 EDT
Volume:44.84M
Turnover:1.17B
Market Cap:147.29B
PE:18.41
High:26.62
Open:26.57
Low:25.87
Close:26.64
Loading ...

What To Expect in the Markets This Week

Investopedia
·
02 Feb

Altria Is the New Dividend Leader in the S&P 500. Shares Yield Nearly 8%. -- Barrons.com

Dow Jones
·
01 Feb

The Week Ahead: Tech earnings continue, January employment reports due

Bloomberg
·
01 Feb

What to Watch in the Week Ahead and on Monday, February 3

Reuters
·
01 Feb

Pfizer Dec-Quarter Net Profit 1.28 Billion Rupees

Reuters
·
31 Jan

Ema Says Chmp Granted Positive Opinion for Tivdak (Tisotumab Vedotin) for Treatment of Recurrent or Metastatic Cervical Cancer

THOMSON REUTERS
·
31 Jan

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
31 Jan

Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’

Insider Monkey
·
31 Jan

Pfizer (PFE) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks
·
30 Jan

Exploring Analyst Estimates for Pfizer (PFE) Q4 Earnings, Beyond Revenue and EPS

Zacks
·
30 Jan

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

PR Newswire
·
30 Jan

RFK Jr. Hearing Kicks Off With Nomination Under Fire -- Barrons.com

Dow Jones
·
29 Jan

Is Pfizer Inc. (PFE) the Safe Stock to Buy for the Long Term in 2025?

Insider Monkey
·
29 Jan

RFK Jr. Goes to Capitol Hill. His Record Jeopardizes HHS Nomination. -- Barrons.com

Dow Jones
·
29 Jan

Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

GlobeNewswire
·
29 Jan

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

GlobeNewswire
·
29 Jan